Your cart is currently empty!
-
Allumiqs and RayBiotech Forge Strategic Alliance to Advance Translational Biomarker Research
This collaboration bridges advanced proteomics with multiomics analytics, enabling researchers to move seamlessly from discovery to clinic.
-
Allumiqs Enhances Advanced Biomarker Discovery Capabilities with Alamar’s ARGO™ HT System
Allumiqs is strengthening its customer solutions with capabilities in detecting and quantifying proteins at unprecedented levels of sensitivity and accuracy.
-
New partnership to accelerate scientific innovation
Allumiqs is excited to announce a new strategic partnership with The Research Institute of McGill University Health Centre (The Institute), a world-renowned biomedical and healthcare…
-
Allumiqs Announces Derek Gooderham’s Appointment to Board of Directors
Halifax, Nova Scotia, September 16, 2024 – Allumiqs, a tech-enabled multiomics contract research organization (CRO), today announced the appointment of Derek Gooderham to its Board…
-
Allumiqs expands metabolomics solutions as part of the biocrates Certified Laboratory Program
Allumiqs announced today that it is now a member of the biocrates Certified Laboratory Program, becoming the only Contract Research Organization (CRO) in North America…
-
American Society for Mass Spectrometry 2024 Annual Conference
We’re excited to once again connect with our mass spectrometry community at ASMS 2024, June 2-6 in sunny Anaheim, CA.
-
Allumiqs and Prolytix form strategic partnership to accelerate drug discovery and development
Allumiqs and Prolytix, today announced their long-term, strategic partnership focused on delivering collaborative and integrated solutions to help customers optimize drug development pipelines.
-
PhenoSwitch Bioscience is now Allumiqs
PhenoSwitch Bioscience is now Allumiqs. For the past year we have been operating as PhenoSwitch Bioscience – A Division of Allumiqs. We are excited to…
-
Proteoform Scientific becomes Allumiqs Corporation
New name, expanded tools, services and solutions for biotech and biopharma
-
Proteoform Scientific Joins Forces with PhenoSwitch Bioscience
New alliance focused on expanding multiomics and data analytics solutions